Cargando…
Prediction of the Risk of Hospital Deaths in Patients with Hospital-Acquired Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii Infection: A Multi-Center Study
PURPOSE: To predict the risk of hospital deaths in patients with hospital-acquired pneumonia (HAP) caused by multidrug-resistant Acinetobacter baumannii (MDR-AB) infection. PATIENTS AND METHODS: A total of 366 patients who were diagnosed with HAP caused by MDR-AB infection were enrolled between Janu...
Autores principales: | Shu, Hongmei, Li, Lijuan, Wang, Yimin, Guo, Yiqun, Wang, Chunlei, Yang, Chunxia, Gu, Li, Cao, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683351/ https://www.ncbi.nlm.nih.gov/pubmed/33244244 http://dx.doi.org/10.2147/IDR.S265195 |
Ejemplares similares
-
Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii
por: Zhou, Yangang, et al.
Publicado: (2019) -
Outcomes and prognostic factors of tigecycline treatment for hospital-acquired pneumonia involving multidrug-resistant Acinetobacter baumannii
por: Liu, Ben, et al.
Publicado: (2020) -
Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals
por: Ibrahim, Susan, et al.
Publicado: (2021) -
A Case of Community-Acquired Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii in Korea
por: Son, Young Woong, et al.
Publicado: (2017) -
Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis
por: Zilberberg, Marya D., et al.
Publicado: (2016)